• Fund Type: OEIC
  • Objective: Global Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: Global

CF Eclectica Absolute Macro Fund

+ Add to Watchlist

CFEGCEA:LN

1.21 EUR -0.00-0.15%

As of 00:59:30 ET on 10/01/2014.

Snapshot for CF Eclectica Absolute Macro Fund (CFEGCEA)

Year To Date: -1.97% 3-Month: +2.45% 3-Year: +1.50% 52-Week Range: 1.10 - 1.25
1-Month: +3.88% 1-Year: +1.95% 5-Year: - Beta vs UKX: 0.52

Mutual Fund Chart for CFEGCEA

No chart data available.
  • CFEGCEA:LN 1.21
  • 1M
  • 1Y
Interactive CFEGCEA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CFEGCEA

CF Eclectica Absolute Macro Fund is an open-end investment company incorporated in the United Kingdom. The Fund's objective is to generate positive and uncorrelated absolute returns in all market conditions over a 12 month period. The Fund invests in global equity, bonds, foreign exchange, cash, other financial instruments and, indirectly, in commodities.

Inception Date: 07-01-2008 Telephone: 44-870-607-2555
Managers: HUGH HENDRY
Web Site: www.capitafinancial.co.uk

Fundamentals for CFEGCEA

NAV (on 2014-10-01) 1.21
Assets (M) (on 2014-08-29) 39.94
Fund Leveraged N
Minimum Investment 20,000,000.00
Minimum Subsequent Investment 10,000.00

Dividends for CFEGCEA

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for CFEGCEA

Front Load 1.00
Back Load 0.00
Current Mgmt Fee 1.25
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.40

Top Fund Holdings for CFEGCEA

Filing Date: 04/30/2014
Name Position Value % of Total
BUBILL 0 09/24/14 10,000 8,219,652 13.431%
BUBILL 0 10/29/14 5,000 4,109,538 6.715%
iShares Euro High Yield Corpor 43,550 3,935,594 6.431%
Sanofi 50,150 3,221,729 5.264%
Novartis AG 60,900 3,131,538 5.117%
Nikkei 225 879 3,108,517 5.079%
Roche Holding AG 17,210 2,996,840 4.897%
GlaxoSmithKline PLC 181,410 2,961,972 4.840%
AstraZeneca PLC 37,560 1,748,700 2.857%
Novo Nordisk A/S 58,210 1,568,137 2.562%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil